default author photo

Yper Hall

UK Health Security Agency

London

United Kingdom

  • UK Health Security Agency

SCHOLARLY PAPERS

2

DOWNLOADS

128

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Rvsv-Zebov Vaccination in People with Pre-Existing Immunity to Ebolavirus: An Open-Label Safety and Immunogenicity Study in Guinean Communities Affected by Ebola Virus Disease (L’Essai Proches)

Number of pages: 18 Posted: 09 May 2024
Conall H. Watson, Pierre-Stéphane Gsell, Yper Hall, Anton Camacho, Ximena Riveros, Godwin Enwere, Andrea Vicari, Séverine Danmadji Nadlaou, Alhassane Toure, Ismaila M. Sani, Abdourahamane Diallo, Aboubacar Barry, Cece Kolie, Sophie Duraffour, Andre Maomou, Kassie Dore, Honora A. Djidonou, Aminata Bagayoko, Philos P. Damey, Mabetty Camara, Fatoumata Battouly Diallo, Thierno Oumar Fofana, Kalidou Toure, Mohamed Diaby, Lansana Sylla, Doussou Conde, Ibrahima Lansana Kaba, Tom Tipton, Rosalind M. Eggo, Michael Marks, Chrissy H. Roberts, Thomas Strecker, Stephan Günther, Sakoba Keita, W. John Edmunds, Miles W. Carroll and Ana Maria Henao Restrepo
UK Health Security Agency, World Health Organization (WHO), UK Health Security Agency, Epicentre (Paris), World Health Organization (WHO), World Health Organization (WHO), Pan American Health Organization, World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), Bernhard-Nocht-Institute for Tropical Medicine (BNITM), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), Gamal Abdel Nasser University, World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), University of Oxford - Pandemic Sciences Institute, London School of Hygiene & Tropical Medicine - Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine - Department of Clinical Research, London School of Hygiene & Tropical Medicine, University of Marburg, Bernhard-Nocht-Institute for Tropical Medicine (BNITM), World Health Organization (WHO), London School of Hygiene & Tropical Medicine, University of Oxford - Wellcome Trust Centre for Human Genetics and Independent
Downloads 103 (679,608)

Abstract:

Loading...

Ebola virus disease, Ebola, vaccine, rVSV-ZEBOV, safety, immunogenicity, cohort study

2.

A modified vaccinia Ankara (MVA) virus vectored Zika vaccine that generates neutralising antibodies and potent T cell responses in type I interferon deficient mice

Number of pages: 35 Posted: 30 Jun 2026
Krishanthi Subramaniam, Gareth Platt, James Austin, Karen Buttigieg, John Bish, Naomi Coombes, Yper Hall, Lynsey Goodwin, Shona C. Moore, Sue Charlton, Hayley Hardwick, Tom Solomon, Gerd Sutter, Miles W. Carroll, Thomas Blanchard, Neil French and Lance Turtle
University of Liverpool - Department of Clinical Infection Microbiology and Immunology, University of Liverpool, University of Liverpool, affiliation not provided to SSRN, affiliation not provided to SSRN, Public Health England - National Infection Service, UK Health Security Agency, University of Liverpool - Department of Clinical Infection, Microbiology and Immunology, University of Liverpool - Institute of Infection, Veterinary and Ecological Sciences, Public Health England - National Infection Service, University of Liverpool, University of Liverpool - Institute of Infection, Veterinary and Ecological Sciences, Ludwig Maximilian University of Munich (LMU), University of Oxford - Wellcome Trust Centre for Human Genetics, University of Liverpool, University of Liverpool and University of Liverpool - NIHR Health Protection Research Unit in Emerging and Zoonotic Infections
Downloads 25

Abstract:

Loading...

Zika virus, modified vaccinia Ankara (MVA), T cells, antibodies, Vaccine, A129 mice